David Emerson Jorden, Dipexium Pharmaceuticals, Inc.'s Acting Chief Financial Officer, appears to have filed an empty initial statement of beneficial ownership. This form is usually filed as a prelude to a company officer either receiving options or buying company shares, so there may be more to come from Jorden.
Here is the filing.
To get notified when Dipexium Pharmaceuticals, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
Regulation FD - Jan. 8, 2018